Navigation Links
Kinex Pharmaceuticals To Present at ASCO 2009 Annual Meeting
Date:5/27/2009

BUFFALO, N.Y., May 27 /PRNewswire/ -- Kinex Pharmaceuticals will present results from a Phase 1 clinical study with KX2-391, at the ASCO 2009 Annual Meeting in Orlando, on May 29, 2009. The study was carried out at MD Anderson, Roswell Park Cancer Institute (RPCI) and Fox Chase Cancer Center. Dr. Alex Adjei, the Principal Investigator from RPCI will deliver the presentation entitled "Results of a phase I trial of KX2-391, a novel non-ATP competitive substrate-pocket directed SRC inhibitor, in patients with advanced malignancies."

The presentation will provide data from this multi-center Phase 1 trial that utilized the standard 3+3 design to determine the Maximum Tolerated Dose (MTD), safety, and pharmacokinetics (PK) of KX2-391 in patients with refractory solid tumors. Patients who responded to treatment will be highlighted.

This presentation was designated as Best of ASCO(R) which features high-impact abstracts from the 2009 ASCO Annual Meeting that represent the most relevant, cutting-edge science in oncology today. This information has been selected to be presented at meetings in the US and internationally because it highlights the latest scientific findings in primary disease sites and practice-changing advances in cancer prevention and treatment.

Kinex Pharmaceuticals is a drug discovery and development company that is focused on next generation drugs to treat cancer and immuno-inflammatory diseases. The Company has utilized its platform technologies to identify highly selective inhibitors of therapeutically relevant targets that are involved in signal transduction and cell cycle control.

CONTACT: Lyn Dyster, Vice President, Research Operations of Kinex Pharmaceuticals, +1-716-881-8984


'/>"/>
SOURCE Kinex Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 2015 Research and ... of the "Investigation Report on China,s Quetiapine ... Developed by AstraZeneca plc, quetiapine (under the ... for the treatment of schizophrenia. Approved by CFDA ... in the Catalogue of Drugs for the Basic ...
(Date:8/28/2015)... August 28, 2015 The scientific team ... with one of the leading academics in the field of ... record holder in life extension for model animals - 10 ... of aging and age-related diseases, primarily, around the stability and ... just been published as "Stability analysis of a model gene ...
(Date:8/28/2015)... Denmark and ATLANTA ... 31, 2015 the US Food and Drug Administration (FDA) cleared ... Depressive Disorder in adult patients who have failed to receive ... TMS is a non-invasive technique for stimulating neural tissue in ... Major Depressive Disorder. The procedure has been proven safe and ...
Breaking Medicine Technology:China Quetiapine Market Investigation Report 2010-2019 2Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3
... enrollment is complete in,the first randomized, prospective, ... and cost-effectiveness of a physiologic-guided,percutaneous coronary intervention ... with multivessel coronary artery disease (CAD). Bernard ... today at the Transcatheter,Cardiovascular Therapeutics symposium (TCT ...
... Phase III - - Conference Call Scheduled ... LA JOLLA, Calif., Oct. 22 TorreyPines,Therapeutics, Inc. (Nasdaq: ... endpoint in a 306-patient, Phase IIb clinical trial for ... study, which evaluated,tezampanel administered subcutaneously, the 40 mg dose ...
Cached Medicine Technology:Patient Enrollment Complete in First Trial to Compare Physiologic Guidance vs. Angiographic Guidance of Stent Deployment in Patients with Multivessel Disease 2Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache 2Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache 3Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache 4Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache 5Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache 6Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache 7Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache 8
(Date:8/29/2015)... ... August 29, 2015 , ... It can be uncomfortable to ... urine and sweat. "In order to prevent these problems, I conceived of my ... ENHANCED MEN'S UNDERGARMENT provides optimal support for a male’s crotch. It improves comfort ...
(Date:8/29/2015)... ... ... Brands like Toppik , Eau Thermale Avene and Bliss are now ... of $49.00 was required to qualify for free standard shipping,” said Jennifer Ramirez, the ... customers regardless of the item’s selling price.” , With competitive pricing in the e-commerce ...
(Date:8/29/2015)... Calgary, AB (PRWEB) , ... August 29, 2015 ... ... congestive heart failure, angina, chronic obstructive pulmonary disease (including emphysema), or asthma, are ... conditions such as angina, previous heart attack, heart failure or heart-rhythm problems (arrhythmia ...
(Date:8/29/2015)... (PRWEB) , ... August 29, 2015 , ... ... the company to freely market and sell Arterosil and Arterosil HP, and that ... Sciences, LLC (DHS) sued Vascular Health Sciences, LLC (VHS) in the United States ...
(Date:8/28/2015)... ... , ... An online provider of CPAP machines, masks, supplies, and accessories, My ... affordable by offering shipping at no cost to you, directly to your door on ... size. My Cpap Store is located in Las Vegas, Nevada. , Sleep apnea is ...
Breaking Medicine News(10 mins):Health News:Modified Men’s Underwear Promote More Comfort and Hygiene - Designed by InventHelp Client (LGI-1968) 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:Heart Fit Clinic Sounds the Alarm on Forest Fire Smoke and Chronic Heart Disease in Calgary Area 2Health News:My Cpap Store Now Offering Delivery Special 0 Cost to You 2
... SUNNYVALE, Calif., Sept. 7 Kyphon Inc.,(Nasdaq: ... 16, 2007, as the,date of the Special Meeting of ... owned subsidiary of Medtronic. The special meeting will ... headquarters located at 1221 Crossman Avenue, Sunnyvale,California 94089. Kyphon ...
... 6 LifeQuest World,Corporation (formerly PhytoLabs Inc.) announced today ... was a contest to allow the,public to participate in ... on June 30, 2007. The company was unable to ... random draw prize of a trip for two to,Las ...
... 6 Democratic National,Committee Chairman Howard Dean addressed ... Dean discussed the important role faith and,morality play ... Democratic,Party, as well as the work people of ... our country and planet, including reconstruction of the,Gulf ...
... Foundation,for Taxpayer and Consumer Rights (FTCR) said today that ... what hospitals will pay in,fees for access to more ... Yesterday, FTCR sent a letter to legislative leaders urging ... limits placed on how much,individuals and employees will pay ...
... 6 AFT Michigan looks forward,to Saturday, September 8,s ... Saturday Michigan environmental, health care, education, women,s and,civil rights, ... the Lansing Center to build a common action agenda ... "The future of our state hangs in the balance," ...
... Sept. 6 The University of,Texas at Austin,s ... the "Length of Prescription Drug Payment Times by ... the slow,reimbursement pharmacies have endured with Medicare Part ... for the Senate and House to,pass S.1954, the ...
Cached Medicine News:Health News:Kyphon Announces Special Meeting Date to Vote on Proposed Medtronic Merger 2Health News:Kyphon Announces Special Meeting Date to Vote on Proposed Medtronic Merger 3Health News:LifeQuest Announces End of Immunity Health Challenge Contest 2Health News:Excerpts from DNC Chairman Howard Dean's Remarks at the National Baptist Convention 2Health News:Excerpts from DNC Chairman Howard Dean's Remarks at the National Baptist Convention 3Health News:Excerpts from DNC Chairman Howard Dean's Remarks at the National Baptist Convention 4Health News:University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix 2Health News:University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix 3
... Rim Implants provide the surgeon ... augmentation of the inferior and ... or secondary rim repair. The ... projection and extends around the ...
Flattened points in vertical plane, straight shafts, cross action, round handle....
Phaco chopper delicate rounded tip....
Nucleus chopper....
Medicine Products: